BRPI0411621A - métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga - Google Patents
métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autólogaInfo
- Publication number
- BRPI0411621A BRPI0411621A BRPI0411621-6A BRPI0411621A BRPI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- fat
- derived cells
- adipose tissue
- transfer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
"MéTODOS DE USO DE CéLULAS DERIVADAS DE TECIDO ADIPOSO NO AUMENTO DE TRANSFERêNCIA DE GORDURA AUTóLOGA". São descritos métodos de tratamento de pacientes para condições tais como aumento dos seios, defeitos do tecido brando e incontinência urinária. Os métodos incluem a remoção de tecido adiposo de um paciente, o processamento de uma porção do tecido adiposo para se obter uma população substancialmente isolada de células regenerativas, a mistura das células regenerativas com uma outra porção de tecido adiposo para formar uma composição, e a administração da composição ao paciente do qual o tecido adiposo foi removido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47941803P | 2003-06-18 | 2003-06-18 | |
PCT/US2004/019611 WO2005011569A2 (en) | 2003-06-18 | 2004-06-18 | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0411621A true BRPI0411621A (pt) | 2006-08-08 |
Family
ID=34115306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0411621-6A BRPI0411621A (pt) | 2003-06-18 | 2004-06-18 | métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1638507B1 (pt) |
JP (1) | JP4722041B2 (pt) |
KR (1) | KR101145508B1 (pt) |
CN (1) | CN101415451A (pt) |
AU (1) | AU2004260638A1 (pt) |
BR (1) | BRPI0411621A (pt) |
CA (1) | CA2529954A1 (pt) |
DK (1) | DK1638507T3 (pt) |
WO (1) | WO2005011569A2 (pt) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
KR100811537B1 (ko) | 2005-03-11 | 2008-03-20 | 양영일 | 지방조직 치료제의 조성, 이들 제조방법 및 그의 전달방법 |
US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
US8062286B2 (en) | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
US20110206643A1 (en) * | 2005-06-02 | 2011-08-25 | In Motion Investment, Ltd. | Automated Cell Therapy System |
KR100764640B1 (ko) * | 2006-03-08 | 2007-10-10 | 세원셀론텍(주) | 지방조직 수복용 키트 |
JP5259929B2 (ja) * | 2006-04-25 | 2013-08-07 | 株式会社カネカ | 脂肪組織から幹細胞を採取するのに適した細胞分離装置、およびその方法 |
CN101473030A (zh) * | 2006-06-15 | 2009-07-01 | Rnl生物技术株式会社 | 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物 |
JP5155530B2 (ja) * | 2006-07-25 | 2013-03-06 | 株式会社カネカ | 成体幹細胞分離・培養システム |
US20100092432A1 (en) * | 2006-08-08 | 2010-04-15 | Takenori Ozaki | Cell preparation containing multipotential stem cells originating in fat tissue |
JP5196890B2 (ja) * | 2007-06-29 | 2013-05-15 | オリンパス株式会社 | 有核細胞回収装置および有核細胞の回収方法 |
JP2009095309A (ja) * | 2007-10-18 | 2009-05-07 | Olympus Corp | 生体組織分解装置および生体組織分解方法 |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
FI20085839A0 (fi) * | 2008-09-08 | 2008-09-08 | Timo Ylikomi | Menetelmiä ja välineitä pehmytkudosteknologiaan |
US9284523B2 (en) * | 2008-10-27 | 2016-03-15 | Terumo Bct, Inc. | Premounted fluid conveyance assembly for cell expansion system and method of use associated therewith |
JP2010178830A (ja) * | 2009-02-04 | 2010-08-19 | Olympus Corp | 生体移植材とその製造方法 |
KR101644534B1 (ko) * | 2009-05-01 | 2016-08-01 | 비미니 테크놀로지스 엘엘씨 | 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물 |
KR101316573B1 (ko) * | 2009-10-27 | 2013-10-15 | 도병록 | 재생성 세포 추출유닛 및 재생성 세포 추출시스템 |
US8673639B2 (en) * | 2009-11-17 | 2014-03-18 | Hee Young Lee | Methods for isolating stem cells |
CN102906250A (zh) * | 2010-02-23 | 2013-01-30 | 赛巴纳医药有限公司 | 提高脂肪移植物存活率的方法和组合物 |
EP2556141B1 (en) | 2010-04-09 | 2019-05-01 | Terumo BCT, Inc. | Air removal chamber for a cell expansion system and method of use associated therewith |
WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
CN102151153A (zh) * | 2011-03-25 | 2011-08-17 | 吴成翰 | 外科手术过程中组织碎片的回收装置 |
US9433645B2 (en) * | 2012-04-13 | 2016-09-06 | Jeong Chan Ra | Method and composition for preventing stem cell disruption and aggregation |
US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
JP6383938B2 (ja) * | 2014-02-04 | 2018-09-05 | 国立大学法人名古屋大学 | 高濃度脂肪組織由来間葉系幹細胞含有脂肪による声門閉鎖不全の治療 |
US20160361476A1 (en) * | 2014-02-28 | 2016-12-15 | Bdbc Sciences Corp. | System for tissue manipulation |
US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
US9988599B2 (en) | 2014-08-25 | 2018-06-05 | Reviticell Holdings, Inc. | Modular single-use kits and methods for preparation of biological material |
EP3660374B1 (en) | 2015-06-19 | 2022-08-17 | ROCKWOOL International A/S | Intumescent fire sleeve, coil of several intumescent fire sleeves and method for installation of an intumescent fire sleeve |
US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
JP7072228B2 (ja) | 2016-06-08 | 2022-05-20 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 組織および細胞を処理するための方法および装置 |
CN106367320B (zh) * | 2016-11-21 | 2023-11-14 | 上海美致臻生物医学科技有限公司 | 一种手动脂肪核心集群细胞、脂肪基质血管组分采集器 |
CN106860923A (zh) * | 2017-01-24 | 2017-06-20 | 北京欧扬医疗美容门诊部有限公司 | 一种短期维持脂肪细胞活性的多功能自体脂肪移植装置 |
KR20190019001A (ko) | 2017-08-16 | 2019-02-26 | (주)제이월드 | 지방분리용 장치 및 지방분리용 장치를 이용한 지방세포 분리 방법 |
US11272996B2 (en) | 2019-10-04 | 2022-03-15 | Reviticell Holdings, Inc. | Methods and devices for performing sequential procedures utilizing a standardized system |
KR102091151B1 (ko) * | 2019-10-08 | 2020-03-20 | 주식회사 로킷헬스케어 | 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트 |
KR102586028B1 (ko) * | 2019-10-08 | 2023-10-10 | 주식회사 로킷헬스케어 | 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트 |
US20240042100A1 (en) * | 2020-12-24 | 2024-02-08 | Rokit Healthcare Inc. | Method of manufacturing a tissue regeneration patch |
FR3134959B1 (fr) * | 2022-04-29 | 2024-05-03 | Neosyad | Procédé et machine de transplantation de graisse |
FR3135200A1 (fr) * | 2022-05-09 | 2023-11-10 | Neosyad | Dispositif de purification de tissu adipeux |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087570A (en) * | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
FR2742662B1 (fr) | 1995-12-21 | 1998-01-23 | Centre Nat Rech Scient | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments |
US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
CA2327789C (en) | 1998-04-07 | 2007-09-04 | Macropore, Inc. | Membrane with tissue-guiding surface corrugations |
US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
AU3081801A (en) | 1999-11-15 | 2001-05-30 | Chemclean Corporation | Bio-burden visualization system |
PT1265550E (pt) | 2000-03-10 | 2005-10-31 | Mast Biosurgery Ag | Micro reabsorvivel para atenuacao de tecido cicatricial |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
AU2002211449A1 (en) | 2000-10-04 | 2002-04-15 | James Peter Amis | Non-scatterable, radio-opaque marker for medical imaging applications |
JP4653952B2 (ja) * | 2001-12-07 | 2011-03-16 | サイトリ セラピューティクス インコーポレイテッド | 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法 |
JP4749331B2 (ja) * | 2003-10-07 | 2011-08-17 | 株式会社バイオマスター | 脂肪由来前駆細胞の細胞分化 |
-
2004
- 2004-06-18 JP JP2006517438A patent/JP4722041B2/ja not_active Expired - Lifetime
- 2004-06-18 AU AU2004260638A patent/AU2004260638A1/en not_active Abandoned
- 2004-06-18 CA CA002529954A patent/CA2529954A1/en not_active Abandoned
- 2004-06-18 DK DK04776784.3T patent/DK1638507T3/en active
- 2004-06-18 WO PCT/US2004/019611 patent/WO2005011569A2/en active Application Filing
- 2004-06-18 KR KR1020057024356A patent/KR101145508B1/ko active IP Right Grant
- 2004-06-18 BR BRPI0411621-6A patent/BRPI0411621A/pt not_active Application Discontinuation
- 2004-06-18 EP EP04776784.3A patent/EP1638507B1/en not_active Expired - Lifetime
- 2004-06-18 CN CNA2004800238048A patent/CN101415451A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
DK1638507T3 (en) | 2017-06-19 |
CN101415451A (zh) | 2009-04-22 |
JP4722041B2 (ja) | 2011-07-13 |
KR101145508B1 (ko) | 2012-05-15 |
CA2529954A1 (en) | 2005-02-10 |
WO2005011569A3 (en) | 2009-04-02 |
JP2007536941A (ja) | 2007-12-20 |
EP1638507A2 (en) | 2006-03-29 |
KR20060025180A (ko) | 2006-03-20 |
EP1638507B1 (en) | 2017-03-22 |
WO2005011569A2 (en) | 2005-02-10 |
AU2004260638A1 (en) | 2005-02-10 |
EP1638507A4 (en) | 2009-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0411621A (pt) | métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga | |
Dunn et al. | Development of fibroblast‐seeded ligament analogs for ACL reconstruction | |
Utomo et al. | Preparation and characterization of a decellularized cartilage scaffold for ear cartilage reconstruction | |
Vavken et al. | TRITON‐X is most effective among three decellularization agents for ACL tissue engineering | |
KR20050085079A (ko) | 분화되지 않은 중배엽 세포를 이용한 조직의 치료 | |
Gardien et al. | Progress towards cell-based burn wound treatments | |
BRPI0512831A (pt) | construção de tecido liso, método para preparação de uma construção de tecido liso, uso da construção de tecido liso, e composição | |
KR101340458B1 (ko) | 하이드로겔을 포함하는 연골 이식용 조성물 | |
CN102716515B (zh) | 一种修复半月板撕裂的生物材料及其制备方法 | |
CR8126A (es) | Metodo y dispositivo para tratar osteoartritis , enfermedad, defectos y lesiones del cartilago en la rodilla humana | |
BR0214021A (pt) | Células estromais derivadas de tecido adiposo, composições e métodos para o uso de tais células no tratamento e reparo de qualquer defeito associado ao tecido ocular | |
KR20050014817A (ko) | 자가 섬유아세포를 이용한 치료 | |
Chen et al. | Tissue engineering of tendons: a comparison of muscle-derived cells, tenocytes, and dermal fibroblasts as cell sources | |
Saczko et al. | A simple and established method of tissue culture of human gingival fibroblasts for gingival augmentation. | |
Paredes et al. | Innate tissue properties drive improved tendon healing in MRL/MpJ and harness cues that enhance behavior of canonical healing cells | |
CN103751844A (zh) | 一种抗菌抗降解的猪小肠粘膜脱细胞基质制备方法及其应用 | |
Wang et al. | Hybrid hydrogel composed of hyaluronic acid, gelatin, and extracellular cartilage matrix for perforated TM repair | |
EP3101121B1 (en) | Use of genetically modified odontogenic stem cells | |
Filipo et al. | Rehabilitation of radical mastoidectomy | |
Xu et al. | The use of allogenic adipose-derived stem cells in combination with platelet-rich fibrin for the treatment of cartilage defects in rabbit ear | |
Kadam et al. | Treatment of gingival recession defect using human umbilical cord mesenchymal stem cells cultured on PCL based bone regenerating scaffold: a randomized controlled clinical study | |
CN112680409B (zh) | 一种基于Wnt-5A/Ror2信号通路的软骨细胞增殖方法 | |
Chu et al. | Urine Derived Stem Cells as a Novel Cell Source for Urethral Tissue Regeneration | |
Silva-Carvalho et al. | IBRUTINIB INDUCES ICAM-1 EXPRESSION ON MESENCHYMAL STEM CELLS AND ENHANCES THEIR POTENTIAL TO CONTROL T-CELL RESPONSE | |
Kratz et al. | Tissue Engineering—Body Parts from the Petri Dish |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 5/0775 (2010.01), C12N 5/00 (2006.01), A61P 4 |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |